BIONDINI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 3.537
AS - Asia 1.724
EU - Europa 1.292
AF - Africa 459
SA - Sud America 396
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 17
Totale 7.463
Nazione #
US - Stati Uniti d'America 3.321
SG - Singapore 645
IT - Italia 404
CN - Cina 336
BR - Brasile 263
HK - Hong Kong 153
VN - Vietnam 127
DE - Germania 88
FI - Finlandia 88
SE - Svezia 80
PL - Polonia 59
BJ - Benin 53
FR - Francia 50
RU - Federazione Russa 49
GB - Regno Unito 44
IN - India 41
AR - Argentina 39
TR - Turchia 36
NL - Olanda 34
KR - Corea 30
ZA - Sudafrica 28
IE - Irlanda 27
AT - Austria 25
MX - Messico 24
ES - Italia 23
AL - Albania 21
CI - Costa d'Avorio 21
CA - Canada 20
JP - Giappone 20
ID - Indonesia 19
BD - Bangladesh 18
IQ - Iraq 18
AO - Angola 17
CD - Congo 17
CZ - Repubblica Ceca 17
HU - Ungheria 17
LB - Libano 17
BY - Bielorussia 16
CH - Svizzera 16
GE - Georgia 16
LV - Lettonia 16
ME - Montenegro 16
MU - Mauritius 16
SN - Senegal 16
AU - Australia 15
BE - Belgio 15
CR - Costa Rica 15
EC - Ecuador 15
SA - Arabia Saudita 15
UA - Ucraina 15
VE - Venezuela 15
AZ - Azerbaigian 14
BG - Bulgaria 14
CO - Colombia 14
MD - Moldavia 14
AE - Emirati Arabi Uniti 13
AM - Armenia 13
BB - Barbados 13
BF - Burkina Faso 13
BS - Bahamas 13
LU - Lussemburgo 13
LY - Libia 13
PT - Portogallo 13
TJ - Tagikistan 13
TN - Tunisia 13
UZ - Uzbekistan 13
GT - Guatemala 12
JO - Giordania 12
KG - Kirghizistan 12
KH - Cambogia 12
LC - Santa Lucia 12
PA - Panama 12
PS - Palestinian Territory 12
PY - Paraguay 12
DK - Danimarca 11
GM - Gambi 11
HR - Croazia 11
MZ - Mozambico 11
RE - Reunion 11
RS - Serbia 11
RW - Ruanda 11
BA - Bosnia-Erzegovina 10
BZ - Belize 10
CM - Camerun 10
CU - Cuba 10
EE - Estonia 10
GH - Ghana 10
KE - Kenya 10
MN - Mongolia 10
MW - Malawi 10
NO - Norvegia 10
PH - Filippine 10
PR - Porto Rico 10
RO - Romania 10
SO - Somalia 10
TH - Thailandia 10
CW - ???statistics.table.value.countryCode.CW??? 9
ET - Etiopia 9
GF - Guiana Francese 9
GN - Guinea 9
Totale 7.064
Città #
Fairfield 510
Ashburn 486
Singapore 367
Woodbridge 273
Chandler 222
Houston 188
Seattle 177
Cambridge 169
Hong Kong 147
Wilmington 128
Beijing 125
Ann Arbor 103
Santa Clara 71
Los Angeles 65
Ho Chi Minh City 59
Boardman 53
Cotonou 52
Munich 48
Helsinki 45
Padova 43
San Diego 41
New York 40
Bytom 37
Medford 35
Princeton 33
Roxbury 28
Hefei 27
Dallas 26
Turku 26
São Paulo 25
Des Moines 24
Dublin 24
Hanoi 22
Chicago 20
Trieste 20
Seoul 19
Abidjan 17
Buffalo 16
Dakar 16
Pune 16
Johannesburg 15
Podgorica 15
Vienna 15
Dong Ket 14
Jinan 14
Kinshasa 14
Luanda 14
Pordenone 14
Bridgetown 13
Rio de Janeiro 13
Tokyo 13
Amman 12
Baku 12
Bishkek 12
Castries 12
Council Bluffs 12
Dushanbe 12
Milan 12
Ogden 12
Tbilisi 12
Kigali 11
London 11
Nassau 11
Riga 11
Tashkent 11
Havana 10
Luxembourg 10
Nanjing 10
Panama City 10
Phnom Penh 10
San José 10
Stockholm 10
Tirana 10
Warsaw 10
Ankara 9
Conakry 9
Lappeenranta 9
Lusaka 9
Managua 9
Minsk 9
Ouagadougou 9
Salt Lake City 9
Tallinn 9
Udine 9
Ulan Bator 9
Yerevan 9
Zagreb 9
Accra 8
Azzano Decimo 8
Budapest 8
Chisinau 8
Città Sant'Angelo 8
Dar es Salaam 8
Guatemala City 8
Nairobi 8
Sofia 8
Tripoli 8
Washington 8
Willemstad 8
Atlanta 7
Totale 4.470
Nome #
From cigarette smoking to Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis. Why? 313
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 239
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment 239
Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease 224
Immune inflammation and disease progression in idiopathic pulmonary fibrosis 213
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 211
Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing 207
Clinical and pathologic factors predicting future Asthma in wheezing children: A longitudinal study 197
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology 191
A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients 190
Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence 181
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 181
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) 178
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort Study 171
Alpha-1 antitrypsin deficiency today: New insights in the immunological pathways 165
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department 165
Blood eosinophils relate to atopy and not to tissue eosinophils in wheezing children 163
Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease 161
CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline 161
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies 160
α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency 159
Risk Factors for Development and Severity of COVID-19 in COPD Patients 156
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis 154
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 154
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial 153
Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19 146
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis 142
Exome sequencing reveals immune genes as susceptibility modifiers in a1-antitrypsin deficiency 140
Successful lung retransplantation in a patient with acute fibrinous and organizing pneumonia: A case report 137
Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD) 130
Editorial: New insights in sarcoidosis: from bench to bedside 129
Idiopathic pulmonary fibrosis and lung transplantation: When it is feasible 129
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment 128
The role of bronchoscopy in the diagnosis and management of patients with sars-cov-2 infection 125
Association between leukocyte telomere length (LTL) and functional decline in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic treatment 121
Exome sequencing in diseased and healthy subjects with alpha-1 antitrypsin deficiency 119
Endobronchial solitary fibrous tumors: An enigma for diagnosis 118
Extracellular Vesicles in Lung Cancer: Bystanders or Main Characters? 109
Pulmonary fibrosis secondary to COVID-19: a call to arms? 109
Herpes simplex virus 2 hepatitis in a lung transplant recipient: A diagnostic challenge 106
Tertiary lymphoid structures and B-cell infiltration are IPF features with functional consequences 104
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey 103
Do Circulating Extracellular Vesicles Strictly Reflect Bronchoalveolar Lavage Extracellular Vesicles in COPD? 102
Symptomatic smokers without COPD have physiological changes heralding the development of COPD 99
Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison? 98
Macrophages-derived Factor XIII links coagulation to inflammation in COPD 98
Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease 92
Clinical Applications of Endobronchial Ultrasound (EBUS) Scope: Challenges and Opportunities 90
Unveiling the Cutting-Edge Impact of Polarized Macrophage-Derived Extracellular Vesicles and MiRNA Signatures on TGF-β Regulation within Lung Fibroblasts 81
The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF) 66
What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review 35
Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience 31
Long-Term Macrolides in Chronic Respiratory Diseases: Dusk or a New Dawn? A Narrative Review 11
Non-Specific Pleuritis After Medical Thoracoscopy: The Portrait of an Open Issue and Practical Hints for Its Management 10
Totale 7.594
Categoria #
all - tutte 25.089
article - articoli 22.790
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021541 0 0 0 0 26 28 93 46 88 124 89 47
2021/2022635 23 26 112 46 68 34 18 90 76 11 27 104
2022/2023489 84 33 23 48 84 49 10 42 76 7 27 6
2023/2024461 10 52 49 29 40 86 26 37 22 35 38 37
2024/20251.509 49 115 90 65 137 64 96 115 128 68 262 320
2025/20262.854 329 448 733 974 370 0 0 0 0 0 0 0
Totale 7.594